Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Trisomy Stories

2014-04-09 08:29:15

PHILADELPHIA, April 9, 2014 /PRNewswire/ -- On April 5, 2014, the 20(th) anniversary of the death of Dr. Jerome Lejeune was marked with great celebration in Paris. Dr. Jerome Lejeune died there on April 3, 1994. To his family and "little ones" - as he always called his patients affected by Down syndrome - he was a remarkable man of science who was motivated by a profound love for those he served. He was a father of 5 who dedicated his life to his family, and to the service of his...

2014-01-16 16:24:23

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/322q6g/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/322q6g/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal...

2013-10-23 11:27:14

Genome-wide changes result from silencing extra chromosome, scientists report at ASHG 2013 The first evidence that the underlying genetic defect responsible for trisomy 21, also known as Down syndrome, can be suppressed in laboratory cultures of patient-derived stem cells was presented today (Oct. 22) at the American Society of Human Genetics 2013 annual meeting in Boston. People with Down syndrome are born with an extra chromosome 21, which results in a variety of physical and...

2013-10-22 08:32:06

The MaterniT21 PLUS Test Celebrates its Second Anniversary Since Launch SAN DIEGO, Oct. 22, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21(TM) PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test...

2013-07-24 23:24:55

The media has recently been filled with headlines proclaiming that Down syndrome has been “cured”. These statements are not accurate, but that is not to say the findings are without significance. Philadelphia, PA (PRWEB) July 24, 2013 The media has recently been filled with headlines proclaiming that Down syndrome has been “cured”. Down syndrome, or trisomy 21, is the most common survivable chromosomal abnormality and is caused by the presence at conception of a third copy of...

2013-07-17 12:27:57

Nature Publication Demonstrates Specificity and Versatility of ZFP Technology to Modify the Human Genome RICHMOND, Calif., July 17, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of groundbreaking research using zinc finger DNA-binding protein (ZFP) technology to insert a gene that permanently "silences" the extra copy of chromosome 21, which is the root cause of Down syndrome (DS). This advance, accomplished in induced pluripotent stem...

2013-06-18 23:01:41

From one family to another, the Chengs publish a free book for families dealing with the loss of an infant. Los Angeles, CA (PRWEB) June 18, 2013 In the fall of 2008, Melanie Tioleco-Cheng received the news that no expectant mother ever wants to hear. Her baby was diagnosed with Trisomy 18. As a physician, she knew exactly what this meant for her second child, Macy, and even more about how little her chance of survival was in light of her heart and lung problems. But, how would Melanie...

2013-06-07 12:48:20

New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. Published early online in Ultrasound in Obstetrics & Gynecology, the results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing. Current screening for Down's syndrome, or trisomy 21, and...

2012-11-06 08:28:21

REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it is expanding the verifi® prenatal test capabilities to include detection of the most common sex chromosome abnormalities. Clinicians will now be able to select the sex chromosomes option on the verifi® test to access this addition. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) Beginning December 3, 2012,...

2012-06-04 02:24:18

SAN JOSE, Calif., June 4, 2012 /PRNewswire/ -- Ariosa Diagnostics, Inc., a molecular diagnostics company, announced the publication of its NICE (Non-Invasive Chromosomal Evaluation) Study, an international multicenter prospective, cohort study of more than 4,000 pregnant women at gestational age 10 weeks or later from 50 clinical sites. The study evaluated Harmony Prenatal Test's performance in detecting fetal Trisomy 21 and 18, which cause Down syndrome and Edwards...